Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

Launched on June 12, 2000, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.

Zacks Investment Research • Feb 18, 2026

Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More

Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and diabetes, outpacing Novo Nordisk, which faces a sharp 2026 revenue decline amid fierce competition, pricing pressure, and other factors.

Seeking Alpha • Feb 7, 2026

ETFs to Play as Investors Chase Diversification Amid Tech Rout

From "software-mageddon" to rising AI capex pressuring Big Tech, diversification via defensive and global ETFs gains focus.

Zacks Investment Research • Feb 6, 2026

Final Trades: IBM, Alibaba, Nu Holdings and the IYH

The Investment Committee give you their top stocks to watch for the second half.

CNBC Television • Jan 21, 2026

IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns

iShares U.S. Healthcare ETF receives a hold rating due to concerning signals from its top holdings and elevated valuations. IYH's heavy concentration in LLY, JNJ, and ABBV exposes the fund to slowing growth, regulatory pressures, and high forward P/E ratios. GLP-1 market risks, muted growth at JNJ, and ABBV's patent expirations threaten IYH's forward performance and capital appreciation.

Seeking Alpha • Jan 13, 2026

Healthcare ETF (IYH) Hits New 52-Week High

IYH hits a 52-week high as healthcare gains momentum, lifted by sector strength and rising investor interest in safety and AI-driven tailwinds.

Zacks Investment Research • Nov 25, 2025

Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH

The Investment Committee give you their top stocks to watch for the second half.

CNBC Television • Nov 17, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs

Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.

Zacks Investment Research • Oct 24, 2025

IYH: Healthcare Dashboard For September

This article provides a top-down view of the healthcare sector based on fundamental metrics. Healthcare providers and pharmaceutical/biotechnology subsectors are undervalued versus 11-year averages. Fast facts on iShares U.S. Healthcare ETF, an alternative to XLV.

Seeking Alpha • Sep 17, 2025